Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
MDMA-Assisted Psychotherapy in Veterans With Combat-Related, Refractory PTSD
VA Loma Linda Health Care System
Evaluation of Psilocybin-Assisted Psychotherapy in Treating Severe Depression in Patients With PTSD
Apex Labs Ltd.
Ketamine and Prolonged Exposure in PTSD
Minneapolis Veterans Affairs Medical Center
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response, Pilot Trial
Yale University
MDMA-Assisted Therapy for Stress Disorders in Healthcare Workers
Nautilus Sanctuary
The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
Yale University
Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSD
Queen's University
The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD
Margaux M. Salas, PhD
Ketamine as a Treatment for Post-Traumatic Stress Disorder (PTSD)
Icahn School of Medicine at Mount Sinai
MDMA-Assisted Psychotherapy for Treatment Resistant PTSD in Adolescents
University of California, Los Angeles
Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada)
Lykos Therapeutics
Ketamine Infusion for Comorbid PTSD and Chronic Pain
VA Ann Arbor Healthcare System
Retrospective Evaluation of Ketamine Effectiveness for the Treatment of Acute Battlefield Related Pain
Defense and Veterans Center for Integrative Pain Management
Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSD
Lykos Therapeutics
MDMA for AUD/PTSD Comorbidity
Carolina L Haass-Koffler
Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder
Halucenex Life Sciences Inc.
Mindfulness-based Psilocybin Therapy for PTSD
Anthony P King
Connectivity Changes Associated With Ketamine Assisted Psychotherapy for PTSD
University of New Mexico
Trifecta Research Study
Johns Hopkins University
Ketamine, SGB and Combination Treatment for TBI
Northwestern University
Intensive 7-day Treatment for PTSD Combining Ketamine With Exposure Therapy
Yale University
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)
Lykos Therapeutics
Enhancing Week-long Psychological Treatment for PTSD With Ketamine
Yale University
RCT: Fentanyl Plus Ketamine Versus Fentanyl Alone for Acute Burn Pain
Johns Hopkins University
Chart Review of Patients Undergoing Ketamine Infusions
Brain and Cognition Discovery Foundation
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)
Lykos Therapeutics
CAP-Ketamine for Antidepressant Resistant PTSD
VA Office of Research and Development
Group MDMA-therapy for Veterans With PTSD
Portland VA Research Foundation, Inc
Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSD
Lykos Therapeutics
Ketamine Treatment for PTSD and MDD in TBI
Minneapolis Veterans Affairs Medical Center
Ketamine Infusion Therapy for the Treatment of PTSD in Paramedics
Klarisana Physician Services PLLC
Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD)
Dennis Charney
The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD.
Yale University
Dose Optimization of MDMA-Assisted Therapy for PTSD
Bronx VA Medical Center
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
VA Office of Research and Development
A Multi-site Expanded Access Program for MDMA-assisted Psychotherapy for Patients With Treatment-resistant PTSD
Lykos Therapeutics
Intraoperative Subanesthetic Ketamine Versus Dexmedetomidine Infusion for Prevention of Post-traumatic Stress Disorder After Traumatic Brain Surgeries
Zagazig University
Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD
Lykos Therapeutics
Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)
Johns Hopkins University
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
Yale University
Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD
Unity Health Toronto
Frontline Clinician Psilocybin Study
University of Washington
Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSD
Lykos Therapeutics
To Test the Potential Efficacy of Repeated Intranasal Administration of Ketamine as a Treatment for PTSD
Adriana Feder
Ketamine-enhanced Prolonged Exposure Therapy in PTSD
VA Office of Research and Development
Ayahuasca, Esketamine and PTSD
University of Sao Paulo
Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans
Lykos Therapeutics
The Effect of Intravenous Ketamine on Non Suicidal Self Injuries.
Tel-Aviv Sourasky Medical Center
Sustaining Remission From PTSD Using Tuned Vibroacoustic Stimulation (TVS) Following MDMA-Assisted Psychotherapy
Apollo Neuroscience, Inc.
Retrospective Observational Study of Intensity Effects in Psychedelic-assisted Treatment
University Hospital, Geneva
PET Imaging of mGLuR5 With Drug Challenge
Yale University
MDMA for Co-occurring PTSD and OUD After Childbirth
University of New Mexico
Ketamine Safety and Tolerability in Psychiatric Inpatient Care (KetGD)
Medical University of Gdansk
Imaging SV2A in Mood Disorders
Yale University
Assess the Utility of a Speech-based Machine Learning Algorithm to Predict Treatment Response to Psychiatric Interventions
Psyrin Inc.
MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder
Stephen Robert Marder
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients
Texas Tech University Health Sciences Center
MDMA Plus Exposure Therapy for PTSD
Emory University
Psilocybin-Assisted Randomized Therapy
Emory University
Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial
Lykos Therapeutics
Effect of Ketamine and Etomidate During RSI on Long Term Outcomes
Vanderbilt University Medical Center
Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder
Lykos Therapeutics
Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD
Sunstone Medical
Department of Defense PTSD Adaptive Platform Trial - Intervention D - SLS-002
Global Coalition for Adaptive Research
A Phase 2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder (PTSD)
Remedy
Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD)
Nathan Brashares Sackett
Adding Trauma-focused Psychotherapy to Ketamine Treatment for Chronic PTSD
Icahn School of Medicine at Mount Sinai
Ketamine Infusions for PTSD and Treatment-Resistant Depression
Minneapolis Veterans Affairs Medical Center
Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder
Johns Hopkins University
MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder
University of Sydney
Combining Esketamine and Prolonged Exposure Treatment for PTSD (Post Traumatic Stress Disorder)
The University of Texas Health Science Center at San Antonio
A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSD
Lykos Therapeutics
Perceptions of MDMA-Assisted Therapy Among Veterans With PTSD
Albany Research Institute, Inc.
Epigenetics and MDMA-Assisted Psychotherapy for PTSD
University of Southern California
Randomized, Double-blind, Placebo-Controlled Pilot Study of MDMA-assisted Therapy for PTSD
Lykos Therapeutics
Open-Label Psilocybin Study in Transdiagnostic Population
Yale University
TIMBER Psychotherapy and Ketamine Single Infusion in Chronic PTSD
The Cooper Health System
Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder
Ohio State University
MDMA-Assisted CBCT for PTSD vs CBCT RCT
Remedy
Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD
Lykos Therapeutics
Long-Term Safety and Effectiveness of MDMA-Assisted Therapy for PTSD
Lykos Therapeutics
A Study of Psilocybin for PTSD
Johns Hopkins University
The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
COMPASS Pathways
Ketamine and Epigenetic Aging
TruDiagnostic
Developing Anesthesia as Post Traumatic Stress Disorder (PTSD) Therapy
Southern California Institute for Research and Education
RIVER At Home Ketamine Protocols
RIVER Foundation
Ketamine Infusion Therapy for PTSD in Combat Veterans
Klarisana Physician Services PLLC
Combined Ketamine and eCBT Intervention for PTSD
Queen's University
Ketamine-assisted Psychotherapy for Adolescent PTSD (KAP)
University of Wisconsin, Madison
Randomized Placebo-controlled Study of MDMA-assisted Therapy in People With PTSD - Israel
Lykos Therapeutics
Reversal of Battle-Related Aging (ROBRA) in a Special Operations Forces Cohort
Stella Center
Preliminary Effectiveness of Individual and Group MDMA-assisted Therapy for Israeli Veterans With PTSD and Moral Injury.
HaEmek Medical Center, Israel
Northwest Therapies Trauma Psilocybin Study Compassionate Use Study
NWTraumatherapies
A Retrospective Effectiveness Trial of Ketamine-Assisted Psychotherapy in Adult Patients Coping With Mental Health
Field Trip Health
MDMA-assisted Brief Cognitive Behavioral Conjoint Therapy for PTSD
Dr. Leslie Morland
MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder
Lykos Therapeutics
Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
University of Minnesota
MDMA-assisted Massed Prolonged Exposure for PTSD
Healing Breakthrough
Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD
Lykos Therapeutics
State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma
Baylor College of Medicine
More trials available. Refine your search to see specific results.
How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
Read the trial details, eligibility criteria, and what participation involves.
Reach out to the study team using the contact information provided.
Complete the screening process to determine if you're eligible.